Is intravenous recombinant plasminogen activator effective up to 4.5 h after onset of ischemic stroke?

Nature Clinical Practice Cardiovascular Medicine

Volumn 6, Issue 3, 2009, Pages 164-165

  Rothwell, Peter M ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; PLACEBO;

BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; FIBRINOLYTIC THERAPY; HUMAN; NOTE; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; RISK REDUCTION; TREATMENT OUTCOME;

BRAIN ISCHEMIA; FIBRINOLYTIC AGENTS; HUMANS; INFUSIONS, INTRAVENOUS; PLASMINOGEN ACTIVATORS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STROKE; TIME FACTORS; TREATMENT OUTCOME;

EID: 61449155272     PISSN: 17434297     EISSN: 17434300     Source Type: Journal    
DOI: 10.1038/ncpcardio1447     Document Type: Note

References (9)

1. Wahlgren N et al. (2007) Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITSMOST): An observational study. Lancet 369: 275-282
2. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group (1995) Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333: 1581-1587
3. Albers GW et al. (2000) Intravenous tissue-type plasminogen activator for treatment of acute stroke: The Standard Treatment with Alteplase to Reverse Stroke (STARS) study. JAMA 283: 1145-1150
4. Hill MD and Buchan AM (2005) Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study. CMAJ 172: 1307-1312
5. Wardlaw JM et al. Thrombolysis for acute ischaemic stroke. Cochrane Database of Systematic Reviews 2003, Issue 3. Art. No.: CD000213. doi:10.1002/14651858.CD000213
6. Hacke W et al. (2004) Association of outcome with early stroke treatment: Pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 363: 768-774
7. Davis SM et al. (2008) Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): A placebo-controlled randomised trial. Lancet Neurol 7: 299-309
8. Hacke W et al. (2008) Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 359: 1317-1329
9. Sandercock P et al. (2008) The third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke. Trials 9 37